Recon: FDA advisory panel endorses Lilly’s Alzheimer’s therapy; Genfit, Ipsen get accelerated approval for liver disease drug
ReconJason Scott
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States